For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Visible Genetics Inc.

USPTO Granted Patents = 60

% Expired Patents = 1.7

Forward Citations = 1,634

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

James M Dunn (26 out of 27 patents)

John K Stevens (21 out of 29 patents)

Alexandre M Izmailov (12 out of 27 patents)

4. John A Renfrew (12 out of 12 patents)

5. Paul Waterhouse (11 out of 14 patents)

6. James Leushner (10 out of 10 patents)

7. Jean-Michel Lacroix (8 out of 9 patents)

8. May Hui (8 out of 8 patents)

9. Marina T Larson (8 out of 8 patents)

10. Rodney D Gilchrist (7 out of 7 patents)

11. Henryk Zaleski (7 out of 8 patents)

12. Thomas D Yager (5 out of 5 patents)

13. Vrijmoed Chi (4 out of 4 patents)

14. James W Cassidy (4 out of 4 patents)

15. Bruno C Maruzzo (3 out of 5 patents)

Core Competencies:

DNA Sequencing

Electrophoresis

Mutation Detection

Nucleic Acids

HIV Mutations

Genotyping

BRCA1 Gene

p53 Screening

Automated Systems

Micro-Electrophoresis

Isothermal Sequencing

Fluorescence Detection

60 patents: Sort by Forward Citations

1. 6653107 - Method and kit for evaluation of HIV mutations (2003-11-25),

2. 6582577 - Electrophoresis gel cassette (2003-06-24),

3. 6554987 - Method and apparatus for alignment of signals for use in DNA base-calling (2003-04-29),

4. 6503704 - Method, reagent and kit for genotyping human papilloma virus (2003-01-07),

5. 6440664 - Apparatus for sequencing of nucleic acids using multiple dyes (2002-08-27),

6. 6436641 - Method and apparatus for DNA sequencing (2002-08-20),

7. 6432634 - Method, apparatus and kits for sequencing of nucleic acids using multiple dyes (2002-08-13),

8. 6413718 - Method for sequencing of nucleic acid polymers (2002-07-02),

9. 6404907 - Method for sequencing nucleic acids with reduced errors (2002-06-11),

10. 6403303 - Method and reagents for testing for mutations in the BRCA1 gene (2002-06-11),

11. 6397150 - Method and apparatus for sequencing of DNA using an internal calibrant (2002-05-28),

12. 6303303 - Method and system for DNA sequence determination and mutation detection (2001-10-16),

13. 6270963 - Method for testing for mutations in DNA from a patient sample (2001-08-07),

14. 6265152 - Method and kit for evaluation of HIV mutations (2001-07-24),

15. 6261430 - Micro-electrophoresis chip for moving and separating nucleic acids and other charged molecules (2001-07-17),

Visible Genetics Inc. is a biotech company based in Toronto, Canada. Founded in 1993, the company specializes in developing genetic sequencing technologies and diagnostic products. With a focus on genetic testing and analysis, Visible Genetics offers innovative solutions for genetic research, clinical diagnostics, and personalized medicine. Their state-of-the-art platforms and software tools enable scientists and healthcare professionals to accurately detect and interpret genetic variations and mutations. Committed to advancing precision medicine, Visible Genetics contributes to the understanding and treatment of various genetic disorders. For more information about their products and services, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

60 Patents

#23 in Toronto

#230 in Canada

#12,059 in the World

Toronto, Canada

Visible Genetics Inc.

Forward Citations = 1,634

33 inventors:

James M Dunn (26 out of 27 patents)

John K Stevens (21 out of 29 patents)

Alexandre M Izmailov (12 out of 27 patents)

4. John A Renfrew (12 out of 12 patents)

5. Paul Waterhouse (11 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…